keyboard_arrow_up

Global Anti-obesity Drugs Market to Grow at 39.45% CAGR by 2019

Global Anti-Obesity Drugs Market 2015-2019 is the latest addition to Sandlerresearch.org industry research reports collection.

Obesity is a medical condition in which there is surplus accumulation of fat in the body. It is linked with increased illness risk, disability, and death. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure.

Analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 39.45 percent over the period 2014-2019.

Single User License of the report is Available at US $2500

Covered in this Report

The Global Anti-obesity Drugs market can be divided into two segments: Peripherally Acting Anti-obesity Drugs and Centrally Acting Anti-obesity Drugs. This report covers the present scenario and the growth prospects of the Global Anti-obesity Drugs market for the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of FDA approved drugs and OTC medications used in the treatment of obesity that are available in the market.

Global Anti-obesity Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and EMEA regions; it also covers the Global Anti-obesity Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Order a copy of this report at (Prices start at US $2500 for a single user PDF) http://www.sandlerresearch.org/purchase?rname=27744 .

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Arena Pharmaceuticals
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Orexigen Therapeutics
  • Vivus

Other Prominent Vendors

  • Amylin
  • Alizyme
  • Boehringer Ingelheim
  • Eisai
  • Merck
  • Norgine
  • Novo Nordisk
  • Pfizer
  • Rhythm Pharmaceuticals
  • Shionogi USA
  • Takeda Pharmaceutical
  • Zafgan

Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Rate of Incidence and Prevalence
07.1.1 US
07.1.2 Europe
08. Types of Obesity
09. Causes of Obesity
10. Classification of Obesity
11. Market Segmentation by Drug Class
12. Geographical Segmentation
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
21. Key Vendor Analysis
22. Other Reports in this Series

List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Anti-obesity Drugs Market 2013-2018 (US$ million)
Exhibit 3: US Prevalence of Adult Overweight and Obesity (NHANES 2011-2012)
Exhibit 4: US Prevalence of Childhood Overweight and Obesity (NHANES 2011-2012)
Exhibit 5: Types of Obesity
Exhibit 6: Causes of Obesity
Exhibit 7: Global Anti-obesity Drugs Market Segmentation by Drug Class
Exhibit 8: Global Anti-obesity Drugs Market by Geographical Segmentation 2014
Exhibit 9: Arena Pharmaceuticals: Geographical Segmentation
Exhibit 10: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
View all 20 Exhibits

Have any Query on the Report get your Queries Resolved at http://www.sandlerresearch.org/inquire-before-buying?rname=27744 .

About US:

Sandlerresearch.org (http://www.sandlerresearch.org) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.